Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer.
Zeng TM, Yang G, Lou C, Wei W, Tao CJ, Chen XY, Han Q, Cheng Z, Shang PP, Dong YL, Xu HM, Guo LP, Chen DS, Song YJ, Qi C, Deng WL, Yuan ZG.
Zeng TM, et al. Among authors: tao cj.
Nat Commun. 2023 Mar 11;14(1):1340. doi: 10.1038/s41467-023-37030-w.
Nat Commun. 2023.
PMID: 36906670
Free PMC article.
Clinical Trial.